Malta vs Saint Kitts and Nevis: Tuberculosis treatment success rate by type
Malta
98
in 2021
Saint Kitts and Nevis
100
in 2019
Malta rank
9th
Saint Kitts and Nevis rank
1st
Tuberculosis treatment success rate by type over time
- Malta
- Saint Kitts and Nevis
How they compare
Saint Kitts and Nevis currently reports 100 against 98 in Malta, a difference of 2.
The two have swapped places 3 times across 12 shared years of data; in 1995 it was Malta ahead.
Malta ranks 9th and Saint Kitts and Nevis ranks 1st of 194 countries.
Across the 3 decades both report, Malta averaged higher in 2 and Saint Kitts and Nevis in 1.
Head to head by decade
| Decade | Malta | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 91.67 | 45 | 46.67 | Malta |
| 2000s | 79.5 | 47.5 | 32 | Malta |
| 2010s | 52.67 | 100 | 47.33 | Saint Kitts and Nevis |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Malta or Saint Kitts and Nevis?
- Saint Kitts and Nevis, at 100 against 98 in Malta as of 2019.
- What is the difference in tuberculosis treatment success rate by type between Malta and Saint Kitts and Nevis?
- 2, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Malta and Saint Kitts and Nevis?
- 12 years are reported by both, from 1995 to 2012.
- How do Malta and Saint Kitts and Nevis rank globally for tuberculosis treatment success rate by type?
- Malta ranks 9th and Saint Kitts and Nevis ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.